通过可诱导的DNA交叉链接剂高度选择性地抑制黑色素瘤细胞: bis (((catechol) 衍生物
Minghui Bai1, Jing Huang, Xiaolong Zheng
1College of Chemistry and Molecular Sciences, State Key Laboratory of Virology, Wuhan University, Hubei, Wuhan 430072, PR China.
Journal of the American Chemical Society
|October 14, 2010
概括
新的双 (甲基醇) 四级衍生物有选择性地杀死黑色素瘤细胞. 这些化合物通过铁酶诱导的氧化来交叉链接DNA,有效地向癌细胞.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 铁酶是一种参与黑色素生产的酶,在黑色素瘤中发挥作用.
- 开发针对黑色素瘤的向疗法仍然是癌症治疗的一个重大挑战.
研究的目的:
- 设计和合成新的二氧化 (甲基) 四级衍生物.
- 为了研究它们的DNA交叉链接能力由氨酶诱导.
- 为了评估它们对黑色素瘤细胞的选择性细胞毒性.
主要方法:
- 合成二氧化 (甲基醇) 四级衍生物.
- 使用3 - 甲基 - 2 - 二硫氨酸水 (MBTH) 识别关键中间体的铁酶试验.
- 使用MTT测定对B16F1,Hela和CHO细胞系进行细胞毒性评估.
- 细胞内成像,性彗星测定和γ-H2AX免疫光测定以确认DNA相互作用.
主要成果:
- 这种o-氨酸中间体对于由铁酶诱导的DNA交叉链接至关重要.
- 双基醇衍生物对氨酶效率高的黑色素瘤细胞具有选择性细胞毒性.
- 这些化合物在向细胞中形成基化和交叉链接的DNA物种.
- 细胞选择性归因于铁酶介导的氧化和高效的DNA向.
结论:
- 双甲醇四级衍生物对黑色素瘤具有强大和选择性的抗癌活性.
- 铁酶介导的激活是它们向细胞毒性的关键.
- 这些化合物代表了黑色素瘤治疗的有前途的药物类别,利用特定酶的激活来向DNA损伤.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...


